Doi, T., Hosaka, H., Longo-Muñoz, F., Alsina Maqueda, M., Thuss-Patience, P., Santoro, A., & Shitara, K. (2022). Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: Subgroup analysis of a randomized phase 3 study (TAGS).

Doi, Toshihiko, Hisashi Hosaka, Federico Longo-Muñoz, Maria Alsina Maqueda, Peter Thuss-Patience, Armando Santoro, and Kohei Shitara. Efficacy and Safety of Trifluridine/tipiracil in Older and Younger Patients With Metastatic Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized Phase 3 Study (TAGS). 2022.

Doi, Toshihiko, et al. Efficacy and Safety of Trifluridine/tipiracil in Older and Younger Patients With Metastatic Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized Phase 3 Study (TAGS). 2022.